KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Halozyme Therapeutics (HALO) over the last 16 years, with Dec 2024 value amounting to -$262.7 million.

  • Halozyme Therapeutics' Cash from Investing Activities rose 220.38% to $201.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $225.5 million, marking a year-over-year increase of 175.03%. This contributed to the annual value of -$262.7 million for FY2024, which is 171.10% down from last year.
  • As of FY2024, Halozyme Therapeutics' Cash from Investing Activities stood at -$262.7 million, which was down 171.10% from -$96.9 million recorded in FY2023.
  • Over the past 5 years, Halozyme Therapeutics' Cash from Investing Activities peaked at $78.4 million during FY2020, and registered a low of -$487.0 million during FY2022.
  • For the 3-year period, Halozyme Therapeutics' Cash from Investing Activities averaged around -$282.2 million, with its median value being -$262.7 million (2024).
  • In the last 5 years, Halozyme Therapeutics' Cash from Investing Activities surged by 1,512.04% in 2020 and then plummeted by 618.53% in 2021.
  • Over the past 5 years, Halozyme Therapeutics' Cash from Investing Activities (Yearly) stood at $78.4 million in 2020, then plummeted by 618.53% to -$406.3 million in 2021, then dropped by 19.87% to -$487.0 million in 2022, then spiked by 80.10% to -$96.9 million in 2023, then plummeted by 171.10% to -$262.7 million in 2024.